IL104099A - 3-Transformed Compounds-5-Amino-Imidazo [A-1,5] Quinazoline, Preparation and Pharmaceutical Preparations Containing Them - Google Patents
3-Transformed Compounds-5-Amino-Imidazo [A-1,5] Quinazoline, Preparation and Pharmaceutical Preparations Containing ThemInfo
- Publication number
- IL104099A IL104099A IL10409992A IL10409992A IL104099A IL 104099 A IL104099 A IL 104099A IL 10409992 A IL10409992 A IL 10409992A IL 10409992 A IL10409992 A IL 10409992A IL 104099 A IL104099 A IL 104099A
- Authority
- IL
- Israel
- Prior art keywords
- compound
- quinazoline
- cyclopropyl
- imidazo
- oxadiazol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK912042A DK204291D0 (da) | 1991-12-20 | 1991-12-20 | Heterocykliske forbindelser deres fremstilling og anvendelse |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL104099A0 IL104099A0 (en) | 1993-05-13 |
| IL104099A true IL104099A (en) | 1996-07-23 |
Family
ID=8109668
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL10409992A IL104099A (en) | 1991-12-20 | 1992-12-15 | 3-Transformed Compounds-5-Amino-Imidazo [A-1,5] Quinazoline, Preparation and Pharmaceutical Preparations Containing Them |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0619820A1 (fr) |
| JP (1) | JPH07502278A (fr) |
| AU (1) | AU673814B2 (fr) |
| CA (1) | CA2125854A1 (fr) |
| DK (1) | DK204291D0 (fr) |
| FI (1) | FI942963A (fr) |
| IL (1) | IL104099A (fr) |
| NO (1) | NO942301L (fr) |
| NZ (1) | NZ246558A (fr) |
| TW (1) | TW211568B (fr) |
| WO (1) | WO1993013103A1 (fr) |
| ZA (1) | ZA929770B (fr) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK151890D0 (da) * | 1990-06-22 | 1990-06-22 | Ferrosan As | Heterocykliske forbindelser deres fremstilling og brug |
| CN1052724C (zh) * | 1996-07-01 | 2000-05-24 | 瑞安大药厂股份有限公司 | 新的光学活性的2,3－二氢咪唑并[1,2－c]喹唑啉衍生物及其制备方法和用途 |
| KR100864364B1 (ko) | 2005-12-13 | 2008-10-17 | 주식회사 엘지화학 | 신규한 이미다조퀴나졸린 유도체, 이의 제조방법 및 이를이용한 유기전기소자 |
| JP5486928B2 (ja) | 2007-02-26 | 2014-05-07 | ヴァイティー ファーマシューティカルズ，インコーポレイテッド | １１β−ヒドロキシステロイドデヒドロゲナーゼ１のサイクリックウレアおよびカルバメートインヒビター |
| AR069207A1 (es) | 2007-11-07 | 2010-01-06 | Vitae Pharmaceuticals Inc | Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1 |
| WO2009075835A1 (fr) | 2007-12-11 | 2009-06-18 | Vitae Pharmaceutical, Inc | Inhibiteurs cycliques d'urée de la 11-hydroxystéroïde déhydrogénase 1 |
| CA2729998A1 (fr) | 2008-07-25 | 2010-01-28 | Boehringer Ingelheim International Gmbh | Inhibiteurs de la 11 beta-hydroxysteroide deshydrogenase 1 |
| EP2687525B1 (fr) | 2008-07-25 | 2015-09-23 | Boehringer Ingelheim International GmbH | Inhibiteurs cycliques de la 11-bêta-hydroxystéroïde déshydrogénase 1 |
| WO2010089303A1 (fr) | 2009-02-04 | 2010-08-12 | Boehringer Ingelheim International Gmbh | Inhibiteurs cycliques de la 11β-hydroxystéroïde déshydrogénase de type 1 |
| UA109255C2 (ru) | 2009-04-30 | 2015-08-10 | Берінгер Інгельхайм Інтернешнл Гмбх | Циклические ингибиторы 11бета-гидроксистероиддегидрогеназы 1 |
| US8927539B2 (en) | 2009-06-11 | 2015-01-06 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 based on the 1,3-oxazinan-2-one structure |
| EP2448928B1 (fr) | 2009-07-01 | 2014-08-13 | Vitae Pharmaceuticals, Inc. | Inhibiteurs cycliques de la 11-bêta-hydroxystéroïde déshydrogénase 1 |
| JP5860042B2 (ja) | 2010-06-16 | 2016-02-16 | ヴァイティー ファーマシューティカルズ，インコーポレイテッド | 置換５、６及び７員複素環、そのような化合物を含有する医薬及びそれらの使用 |
| WO2011161128A1 (fr) | 2010-06-25 | 2011-12-29 | Boehringer Ingelheim International Gmbh | Azaspirohexanones comme inhibiteurs de 11-β-hsd1 pour le traitement de troubles métaboliques |
| WO2012059416A1 (fr) | 2010-11-02 | 2012-05-10 | Boehringer Ingelheim International Gmbh | Combinaisons pharmaceutiques destinées au traitement de troubles du métabolisme |
| KR20230088709A (ko) * | 2020-10-16 | 2023-06-20 | 상하이 드 노보 파마테크 컴퍼니 리미티드 | 트리헤테로사이클릭 유도체, 이의 약학적 조성물 및 용도 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE80392T1 (de) * | 1985-10-17 | 1992-09-15 | Novo Nordisk As | Oxadiazolylacetonitrile, ihre herstellung und anwendung. |
| DK155524C (da) * | 1987-03-18 | 1989-09-11 | Ferrosan As | Kondenserede imidazolderivater og farmaceutiske praeparater indeholdende disse |
| DK443589D0 (da) * | 1989-09-08 | 1989-09-08 | Ferrosan As | Heterocykliske forbindelser, deres fremstilling og anvendelse |
| DK151890D0 (da) * | 1990-06-22 | 1990-06-22 | Ferrosan As | Heterocykliske forbindelser deres fremstilling og brug |
-
1991
- 1991-12-20 DK DK912042A patent/DK204291D0/da not_active Application Discontinuation
-
1992
- 1992-12-15 IL IL10409992A patent/IL104099A/en not_active IP Right Cessation
- 1992-12-17 ZA ZA929770A patent/ZA929770B/xx unknown
- 1992-12-18 CA CA002125854A patent/CA2125854A1/fr not_active Abandoned
- 1992-12-18 NZ NZ246558A patent/NZ246558A/en unknown
- 1992-12-18 WO PCT/DK1992/000385 patent/WO1993013103A1/fr not_active Application Discontinuation
- 1992-12-18 AU AU33448/93A patent/AU673814B2/en not_active Ceased
- 1992-12-18 EP EP93902092A patent/EP0619820A1/fr not_active Withdrawn
- 1992-12-18 JP JP5511363A patent/JPH07502278A/ja active Pending
- 1992-12-18 TW TW081110173A patent/TW211568B/zh active
-
1994
- 1994-06-17 NO NO942301A patent/NO942301L/no unknown
- 1994-06-20 FI FI942963A patent/FI942963A/fi not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL104099A0 (en) | 1993-05-13 |
| EP0619820A1 (fr) | 1994-10-19 |
| CA2125854A1 (fr) | 1993-07-08 |
| WO1993013103A1 (fr) | 1993-07-08 |
| ZA929770B (en) | 1994-06-17 |
| DK204291D0 (da) | 1991-12-20 |
| JPH07502278A (ja) | 1995-03-09 |
| AU673814B2 (en) | 1996-11-28 |
| FI942963A0 (fi) | 1994-06-20 |
| NO942301L (no) | 1994-08-19 |
| NZ246558A (en) | 1995-07-26 |
| NO942301D0 (no) | 1994-06-17 |
| FI942963A (fi) | 1994-06-20 |
| AU3344893A (en) | 1993-07-28 |
| TW211568B (fr) | 1993-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6105578B2 (ja) | 複素環式プロテインキナーゼ阻害剤 | |
| AU673814B2 (en) | Imidazoquinazoline compounds and their preparation and use | |
| US4774245A (en) | Imidazoquinoxaline compounds | |
| JP2690282B2 (ja) | イミダゾジアゼピン | |
| EP0283162B1 (fr) | Composés hétérocycliques, leur préparation et utilisation | |
| BG102790A (bg) | ПИРИМИДО/5,4-d/ПИРИМИДИНИ, ЛЕКАРСТВЕНИ СРЕДСТВА, СЪДЪРЖАЩИ ТЕЗИ СЪЕДИНЕНИЯ, ПРИЛОЖЕНИЕТО ИМ И МЕТОДЗА ТЯХНОТО ПОЛУЧАВАНЕ | |
| WO2011072696A1 (fr) | Dérivés de 2-arylimidazole en tant qu'inhibiteurs de l'enzyme pde10a | |
| EP0320136B1 (fr) | Composés d'imidazoquinoxaline, leur préparation et utilisation | |
| CZ298906B6 (cs) | Deriváty 1H-pyrido[3,4-b]indol-4-karboxamidu, zpusob jejich prípravy a jejich použití jako lécivo | |
| EP0226282B1 (fr) | Composés hétérocycliques, leur préparation et leur utilisation | |
| AU618366B2 (en) | Imidazoquinoxaline compounds and their preparation and use | |
| AU627181B2 (en) | Imidazoquinoxaline compounds and their preparation and use | |
| JP2003516994A (ja) | 認知能力を向上させるための置換１，２，３−トリアゾロ［１，５−ａ］キナゾリン | |
| US4963553A (en) | 4-[(substituted) alkylcarbonyl]-4,5-dihydro- and -4,5,6,7-tetrahydro-7-[(substituted)phenyl]pyrazolo[1,5-a]pyrimidines | |
| US5276028A (en) | Imidazoquinoxaline compounds | |
| EP0535104B1 (fr) | Composes heterocycliques, leur preparation et utilisation | |
| US5371080A (en) | Imidazoquinazoline compounds and their use | |
| EP0575442B1 (fr) | Derives d'imidazoquinazoline tetracyclique, procede de preparation et compositions pharmaceutiques les contenant | |
| IE59495B1 (en) | Oxadiazolylimidazobenzodiazepines, process for their preparation and pharmaceutical compositions | |
| WO2021210586A1 (fr) | Composé hétérocyclique condensé | |
| IE69960B1 (en) | Imidazoquinoxaline compounds their preparation and use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| RH | Patent void |